Bridge to nowhere: A retrospective single-center study on patients using chronic intravenous inotropic support as bridge therapy who do not receive surgical therapy

BackgroundMany patients with advanced heart failure (HF) are administered chronic intravenous inotropic support (CIIS) as bridge to surgical therapy; some ultimately never receive surgery. We aimed to describe reasons patients “crossover” from CIIS as bridge therapy to palliative therapy, and compar...

Full description

Bibliographic Details
Main Authors: Anirudh Rao, Manavotam Singh, Mansi Maini, Kelley M. Anderson, Nancy A. Crowell, Paul R. Henderson, Sherry S. Gholami, Farooq H. Sheikh, Samer S. Najjar, Hunter Groninger
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.918146/full
_version_ 1811282839308599296
author Anirudh Rao
Anirudh Rao
Manavotam Singh
Mansi Maini
Kelley M. Anderson
Nancy A. Crowell
Paul R. Henderson
Sherry S. Gholami
Farooq H. Sheikh
Farooq H. Sheikh
Samer S. Najjar
Hunter Groninger
Hunter Groninger
author_facet Anirudh Rao
Anirudh Rao
Manavotam Singh
Mansi Maini
Kelley M. Anderson
Nancy A. Crowell
Paul R. Henderson
Sherry S. Gholami
Farooq H. Sheikh
Farooq H. Sheikh
Samer S. Najjar
Hunter Groninger
Hunter Groninger
author_sort Anirudh Rao
collection DOAJ
description BackgroundMany patients with advanced heart failure (HF) are administered chronic intravenous inotropic support (CIIS) as bridge to surgical therapy; some ultimately never receive surgery. We aimed to describe reasons patients “crossover” from CIIS as bridge therapy to palliative therapy, and compare end-of-life outcomes to patients initiated on CIIS as palliative therapy.MethodsSingle-institution, retrospective cohort study of patients on CIIS as bridge or palliative therapy between 2010 and 2016; data obtained through review of health records and multi-disciplinary selection meeting minutes, was analyzed using descriptive and inferential statistics.ResultsOf 246 patients discharged on CIIS as bridge therapy, 37 (16%) (male n = 28, 76%; African American n = 22, 60%) ultimately never received surgery. 67 matched patients on CIIS as palliative therapy were included for analysis (male n = 47, 70%; African American n = 47, 70%). The most common reasons for “crossover” from CIIS as bridge therapy to palliative therapy were frailty (n = 10, 27%), cardiac arrest (n = 5, 13.5%), and progressive non-cardiac illnesses (n = 6, 16.2%). A similar percentage of patients in the bridge (n = 28, 76%) and palliative (n = 48, 72%) groups died outside the hospital (P=0.66); however, fewer bridge patients received hospice care compared to the palliative group (35% vs 69%, P < 0.001). Comparing patients who died in the hospital, bridge patients (n = 9; 100%) were more likely to die in the intensive care unit than palliative patients (n = 8; 42%) (P < 0.001).ConclusionPatients on CIIS as bridge therapy who do not ultimately receive surgical therapy “crossover” to palliative intention due to frailty, or development of or identification of serious illnesses. Nevertheless, these “bridge to nowhere” patients are less likely to receive palliative care or hospice and more likely to die in the intensive care unit than patients on CIIS as palliative therapy.
first_indexed 2024-04-13T01:59:45Z
format Article
id doaj.art-b7a189f9e82c4eeab486c9a4bd5990fb
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-13T01:59:45Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-b7a189f9e82c4eeab486c9a4bd5990fb2022-12-22T03:07:39ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-08-01910.3389/fcvm.2022.918146918146Bridge to nowhere: A retrospective single-center study on patients using chronic intravenous inotropic support as bridge therapy who do not receive surgical therapyAnirudh Rao0Anirudh Rao1Manavotam Singh2Mansi Maini3Kelley M. Anderson4Nancy A. Crowell5Paul R. Henderson6Sherry S. Gholami7Farooq H. Sheikh8Farooq H. Sheikh9Samer S. Najjar10Hunter Groninger11Hunter Groninger12Department of Medicine, Georgetown University School of Medicine, Washington, DC, United StatesSection of Palliative Medicine, Department of Medicine, MedStar Washington Hospital Center, Washington, DC, United StatesMedStar Washington Hospital Center, MedStar Heart and Vascular Institute, Washington, DC, United StatesDepartment of Medicine, Georgetown University School of Medicine, Washington, DC, United StatesGeorgetown University School of Nursing and Health Studies, Washington, DC, United StatesGeorgetown University School of Nursing and Health Studies, Washington, DC, United StatesDepartment of Medicine, Georgetown University School of Medicine, Washington, DC, United StatesDepartment of Medicine, Georgetown University School of Medicine, Washington, DC, United StatesDepartment of Medicine, Georgetown University School of Medicine, Washington, DC, United StatesMedStar Washington Hospital Center, MedStar Heart and Vascular Institute, Washington, DC, United StatesMedStar Washington Hospital Center, MedStar Heart and Vascular Institute, Washington, DC, United StatesDepartment of Medicine, Georgetown University School of Medicine, Washington, DC, United StatesSection of Palliative Medicine, Department of Medicine, MedStar Washington Hospital Center, Washington, DC, United StatesBackgroundMany patients with advanced heart failure (HF) are administered chronic intravenous inotropic support (CIIS) as bridge to surgical therapy; some ultimately never receive surgery. We aimed to describe reasons patients “crossover” from CIIS as bridge therapy to palliative therapy, and compare end-of-life outcomes to patients initiated on CIIS as palliative therapy.MethodsSingle-institution, retrospective cohort study of patients on CIIS as bridge or palliative therapy between 2010 and 2016; data obtained through review of health records and multi-disciplinary selection meeting minutes, was analyzed using descriptive and inferential statistics.ResultsOf 246 patients discharged on CIIS as bridge therapy, 37 (16%) (male n = 28, 76%; African American n = 22, 60%) ultimately never received surgery. 67 matched patients on CIIS as palliative therapy were included for analysis (male n = 47, 70%; African American n = 47, 70%). The most common reasons for “crossover” from CIIS as bridge therapy to palliative therapy were frailty (n = 10, 27%), cardiac arrest (n = 5, 13.5%), and progressive non-cardiac illnesses (n = 6, 16.2%). A similar percentage of patients in the bridge (n = 28, 76%) and palliative (n = 48, 72%) groups died outside the hospital (P=0.66); however, fewer bridge patients received hospice care compared to the palliative group (35% vs 69%, P < 0.001). Comparing patients who died in the hospital, bridge patients (n = 9; 100%) were more likely to die in the intensive care unit than palliative patients (n = 8; 42%) (P < 0.001).ConclusionPatients on CIIS as bridge therapy who do not ultimately receive surgical therapy “crossover” to palliative intention due to frailty, or development of or identification of serious illnesses. Nevertheless, these “bridge to nowhere” patients are less likely to receive palliative care or hospice and more likely to die in the intensive care unit than patients on CIIS as palliative therapy.https://www.frontiersin.org/articles/10.3389/fcvm.2022.918146/fullinotropesStage D heart failurepalliative careLVADheart transplant
spellingShingle Anirudh Rao
Anirudh Rao
Manavotam Singh
Mansi Maini
Kelley M. Anderson
Nancy A. Crowell
Paul R. Henderson
Sherry S. Gholami
Farooq H. Sheikh
Farooq H. Sheikh
Samer S. Najjar
Hunter Groninger
Hunter Groninger
Bridge to nowhere: A retrospective single-center study on patients using chronic intravenous inotropic support as bridge therapy who do not receive surgical therapy
Frontiers in Cardiovascular Medicine
inotropes
Stage D heart failure
palliative care
LVAD
heart transplant
title Bridge to nowhere: A retrospective single-center study on patients using chronic intravenous inotropic support as bridge therapy who do not receive surgical therapy
title_full Bridge to nowhere: A retrospective single-center study on patients using chronic intravenous inotropic support as bridge therapy who do not receive surgical therapy
title_fullStr Bridge to nowhere: A retrospective single-center study on patients using chronic intravenous inotropic support as bridge therapy who do not receive surgical therapy
title_full_unstemmed Bridge to nowhere: A retrospective single-center study on patients using chronic intravenous inotropic support as bridge therapy who do not receive surgical therapy
title_short Bridge to nowhere: A retrospective single-center study on patients using chronic intravenous inotropic support as bridge therapy who do not receive surgical therapy
title_sort bridge to nowhere a retrospective single center study on patients using chronic intravenous inotropic support as bridge therapy who do not receive surgical therapy
topic inotropes
Stage D heart failure
palliative care
LVAD
heart transplant
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.918146/full
work_keys_str_mv AT anirudhrao bridgetonowherearetrospectivesinglecenterstudyonpatientsusingchronicintravenousinotropicsupportasbridgetherapywhodonotreceivesurgicaltherapy
AT anirudhrao bridgetonowherearetrospectivesinglecenterstudyonpatientsusingchronicintravenousinotropicsupportasbridgetherapywhodonotreceivesurgicaltherapy
AT manavotamsingh bridgetonowherearetrospectivesinglecenterstudyonpatientsusingchronicintravenousinotropicsupportasbridgetherapywhodonotreceivesurgicaltherapy
AT mansimaini bridgetonowherearetrospectivesinglecenterstudyonpatientsusingchronicintravenousinotropicsupportasbridgetherapywhodonotreceivesurgicaltherapy
AT kelleymanderson bridgetonowherearetrospectivesinglecenterstudyonpatientsusingchronicintravenousinotropicsupportasbridgetherapywhodonotreceivesurgicaltherapy
AT nancyacrowell bridgetonowherearetrospectivesinglecenterstudyonpatientsusingchronicintravenousinotropicsupportasbridgetherapywhodonotreceivesurgicaltherapy
AT paulrhenderson bridgetonowherearetrospectivesinglecenterstudyonpatientsusingchronicintravenousinotropicsupportasbridgetherapywhodonotreceivesurgicaltherapy
AT sherrysgholami bridgetonowherearetrospectivesinglecenterstudyonpatientsusingchronicintravenousinotropicsupportasbridgetherapywhodonotreceivesurgicaltherapy
AT farooqhsheikh bridgetonowherearetrospectivesinglecenterstudyonpatientsusingchronicintravenousinotropicsupportasbridgetherapywhodonotreceivesurgicaltherapy
AT farooqhsheikh bridgetonowherearetrospectivesinglecenterstudyonpatientsusingchronicintravenousinotropicsupportasbridgetherapywhodonotreceivesurgicaltherapy
AT samersnajjar bridgetonowherearetrospectivesinglecenterstudyonpatientsusingchronicintravenousinotropicsupportasbridgetherapywhodonotreceivesurgicaltherapy
AT huntergroninger bridgetonowherearetrospectivesinglecenterstudyonpatientsusingchronicintravenousinotropicsupportasbridgetherapywhodonotreceivesurgicaltherapy
AT huntergroninger bridgetonowherearetrospectivesinglecenterstudyonpatientsusingchronicintravenousinotropicsupportasbridgetherapywhodonotreceivesurgicaltherapy